Tracing the Satisfactory Care of the Chronically Ill in Emergency Departments: A Scoping Review
Abstract
Aims and objectives: The growing prevalence of chronic diseases has heightened the demand for emergency department (ED) services, underscoring their increasingly essential role within healthcare systems. To improve outcomes and decrease needless ED use, it is essential to comprehend what constitutes appropriate care in this context.
Methodological design: A scoping review was conducted following PRISMA-ScR reporting guidelines. Relevant studies published between 2013 and 2024 were identified through systematic searches conducted in PubMed, Cochrane and Scopus. The methodological approach was based on the Arksey and O'Malley framework, further refined by Levac et al. and Peters et al., and complemented by the Framework 'N' to integrate principles of caring science and patient-centred care within the synthesis process.
Results: Fifteen studies were deemed eligible for inclusion. Four overarching motifs emerged from the thematic synthesis. (1) Health systems: Age and multimorbidity are the main causes of ED dependence. This emphasises the necessity of service reform and customised care programs. (2) ED use and care transitions: Results are enhanced by functional evaluation, timely pain management and organised follow-up. Delays and disjointed aftercare, however, are frequent. (3) Interdisciplinary collaboration: Coordinated multidisciplinary teams and integration with primary care enhance patient satisfaction and continuity. Nevertheless, these methods are rarely used. (4)…
Read the paper
Related studies
- The Matrisome: In Silico Definition and In Vivo Characterization by Proteomics of Normal and Tumor Extracellular Matrices
- The Escherichia coli MG1655 in silico metabolic genotype: Its definition, characteristics, and capabilities
- In silico pharmacology for drug discovery: methods for virtual ligand screening and profiling
- In silico prediction of splice-altering single nucleotide variants in the human genome
- In silico clinical trials: how computer simulation will transform the biomedical industry
- In silico optimization of a guava antimicrobial peptide enables combinatorial exploration for peptide design
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.